We are live on ! Find out more
ADIM

Alpha DNA Investment Management Portfolio holdings

AUM $8.98M
1-Year Est. Return 26.05%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+26.05%
3 Year Est. Return
+134.39%
5 Year Est. Return
10 Year Est. Return
AUM
$257M
AUM Growth
-$13.3M
Cap. Flow
-$15.3M
Cap. Flow %
-5.95%
Top 10 Hldgs %
43.17%
Holding
259
New
67
Increased
65
Reduced
68
Closed
57

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$2.62M
2
MCD icon
McDonald's
MCD
+$2.54M
3
MDLZ icon
Mondelez International
MDLZ
+$2.52M
4
CI icon
Cigna
CI
+$2.32M
5
JPM icon
JPMorgan Chase
JPM
+$2.18M

Sector Composition

Rank Sector Weight
1 Technology 15.39%
2 Financials 13.15%
3 Healthcare 9.82%
4 Consumer Discretionary 6.3%
5 Industrials 5.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NFLX icon
76
Netflix
NFLX
$314B
$748K 0.29%
+11,090
New +$693K
CRWD icon
77
CrowdStrike
CRWD
$226B
$741K 0.29%
7,736
-2,164
-22% -$180K
TT icon
78
Trane Technologies
TT
$107B
$733K 0.28%
+2,228
New +$709K
MANH icon
79
Manhattan Associates
MANH
$11.5B
$687K 0.27%
2,785
-2,574
-48% -$584K
DHI icon
80
D.R. Horton
DHI
$42B
$680K 0.26%
4,824
+1,131
+31% +$166K
GM icon
81
General Motors
GM
$78.6B
$676K 0.26%
14,557
+3,558
+32% +$161K
KLAC icon
82
KLA
KLAC
$260B
$665K 0.26%
8,070
-2,750
-25% -$203K
MRNA icon
83
Moderna
MRNA
$23.9B
$665K 0.26%
+5,601
New +$709K
MPWR icon
84
Monolithic Power Systems
MPWR
$69.1B
$657K 0.26%
800
-460
-37% -$332K
APO icon
85
Apollo Global Management
APO
$80.7B
$609K 0.24%
5,162
+1,261
+32% +$143K
CBOE icon
86
Cboe Global Markets
CBOE
$29.6B
$594K 0.23%
3,495
+806
+30% +$143K
FANG icon
87
Diamondback Energy
FANG
$56.8B
$574K 0.22%
2,869
+610
+27% +$121K
CFR icon
88
Cullen/Frost Bankers
CFR
$10.3B
$565K 0.22%
5,556
-3,450
-38% -$361K
BLD
89
DELISTED
TopBuild
BLD
$562K 0.22%
1,458
+300
+26% +$122K
MGM icon
90
MGM Resorts International
MGM
$11B
$551K 0.21%
+12,402
New +$518K
ZION icon
91
Zions Bancorporation
ZION
$10.3B
$529K 0.21%
+12,208
New +$515K
RSI icon
92
Rush Street Interactive
RSI
$2.9B
$528K 0.21%
+55,050
New +$441K
WT icon
93
WisdomTree
WT
$3.37B
$524K 0.2%
+52,827
New +$497K
TMDX icon
94
Transmedics
TMDX
$3.02B
$518K 0.2%
3,436
-3,301
-49% -$396K
FORM icon
95
FormFactor
FORM
$9.3B
$512K 0.2%
+8,465
New +$441K
OKTA icon
96
Okta
OKTA
$26.1B
$512K 0.2%
5,472
-2,713
-33% -$257K
WTS icon
97
Watts Water Technologies
WTS
$12.9B
$511K 0.2%
2,786
-2,220
-44% -$445K
YOU icon
98
Clear Secure
YOU
$5.08B
$510K 0.2%
27,235
+4,270
+19% +$77.3K
NVT icon
99
nVent Electric
NVT
$27B
$508K 0.2%
6,634
+1,494
+29% +$116K
LEN icon
100
Lennar Class A
LEN
$21.1B
$508K 0.2%
3,499
+826
+31% +$126K

Similar funds

Alpha DNA Investment Management's Q2 2024 Portfolio in Review

As of Q2 2024, Alpha DNA Investment Management held 259 positions worth $257M, down 4.9% from $271M the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Alpha DNA Investment Management withdrew a net $15.3M in Q2 2024, closing 57 positions and reducing 68 holdings. Its most notable exit was Cigna, an estimated $2.32M position sold in full.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Alpha DNA Investment Management opened a new position in Colgate-Palmolive worth $2.32M.

  • Alpha DNA Investment Management's largest Q2 2024 buy was Colgate-Palmolive: 23,939 shares worth $2.32M.
  • Alpha DNA Investment Management added most to Wells Fargo in Q2 2024, an estimated $2.53M increase.
  • Alpha DNA Investment Management's biggest Q2 2024 reduction was Microsoft, cutting an estimated $2.62M.
  • Alpha DNA Investment Management fully exited Cigna in Q2 2024, selling an estimated $2.32M.
  • Alpha DNA Investment Management's ten largest holdings make up 43% of its $257M portfolio in Q2 2024.
  • Alpha DNA Investment Management opened 67 new positions and closed 57 in Q2 2024.
  • Alpha DNA Investment Management's portfolio value fell 4.9% quarter-over-quarter to $257M.

Based on Alpha DNA Investment Management's 13F filing for Q2 2024, filed 14 Aug 2024.